A detailed history of Rhumbline Advisers transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 190 shares of TLRY stock, worth $281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190
Previous 19,038 99.0%
Holding current value
$281
Previous $31,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$1.62 - $2.03 $30,533 - $38,261
-18,848 Reduced 99.0%
190 $0
Q2 2024

Aug 01, 2024

SELL
$1.62 - $2.85 $1,227 - $2,160
-758 Reduced 3.83%
19,038 $31,000
Q2 2023

Aug 08, 2023

BUY
$1.52 - $2.78 $6,584 - $12,042
4,332 Added 28.01%
19,796 $30,000
Q2 2022

Aug 11, 2022

BUY
$3.11 - $7.48 $8,157 - $19,620
2,623 Added 20.43%
15,464 $48,000
Q2 2021

Aug 05, 2021

BUY
$13.68 - $22.34 $175,664 - $286,867
12,841 New
12,841 $232,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $905M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.